The Department of Defense Peer Reviewed Medical Research Program is offering the Clinical Trial Award to support the rapid implementation of clinical trials aimed at impacting diseases in the PRMRP Topic Areas. Projects can include evaluating new products, pharmacologic agents, devices, guidance, and technologies from small proof-of-concept trials to large-scale trials determining efficacy in patient populations. Applications for this grant must be submitted by July 2, 2019.
Opportunity ID: 312034
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-19-PRMRP-CTA |
| Funding Opportunity Title: | CDMRP Peer Reviewed Medical Research Program Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 9 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 15, 2019 |
| Last Updated Date: | Jan 15, 2019 |
| Original Closing Date for Applications: | Jul 02, 2019 |
| Current Closing Date for Applications: | Jul 02, 2019 |
| Archive Date: | Aug 01, 2019 |
| Estimated Total Program Funding: | $58,500,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The PRMRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in at least one of the Congressionally directed FY19 PRMRP Topic Areas. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, Phase 0), to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 312034 Full Announcement-FY19 PRMRP CTA -> PRMRP_FY19_CTA_PA_GG.PDF
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00247558 | Jan 15, 2019 | Jul 02, 2019 | View |
Package 1
Mandatory forms
312034 RR_SF424_2_0-2.0.pdf
312034 AttachmentForm_1_2-1.2.pdf
312034 RR_PersonalData_1_2-1.2.pdf
312034 RR_KeyPersonExpanded_2_0-2.0.pdf
312034 RR_Budget_1_4-1.4.pdf
312034 PerformanceSite_2_0-2.0.pdf
Optional forms
312034 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
